PTCT's logo.
Ticker Symbol: PTCT

PTC Therapeutics Inc

$40.33 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001070081

Company Profile

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and its mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 100 Corporate Ct
CEO: Stuart Peltz
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $20.43
Change: -$0.81 ( -3.81%)
Days Range: $20.39 - $21.35
Beta: 0.77
52wk. High: $59.84
52wk. Low: $19.70
Ytd. Change -48.17%
50 Day Moving Average: $27.08
200 Day Moving Average: $40.78
Shares Outstanding: 75344951

Valuation

Market Cap: 153.9B
PE Ratio: -2.42
EPS (TTM): -8.44

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A